High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease.

By A. Darfeuille‐Michaud, J. Boudeau, P. Bulois, C. Neut, A. Glasser, N. Barnich, M. Bringer, A. Swidsinski, L. Beaugerie, J. Colombel. Gastroenterology, 2004

1,551 citations recorded by the source corpus.

Subfields: Endocrinology, Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/142cd014bab05ff8e9ee83f32c2e120ef010610c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology

1. G. Núñez
2. B. B. Finlay
3. R. Ross
4. C. Stanton
5. M. Zeng
6. B. Sinha
7. Martin J. Fraunholz

In Genetics

1. B. B. Finlay
2. R. Sartor
3. Ted G. Dinan
4. Antonio Gasbarrini
5. Loris Riccardo Lopetuso
6. G. Núñez
7. P. Murray
8. Daniel Falush

In Molecular Biology

1. Ted G. Dinan
2. J. Cryan
3. C. Stanton
4. D. van Sinderen
5. B. B. Finlay
6. M. Zeng
7. H. Smidt
8. N. Juge

Citations in the corpus

• NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation (2010, background): “coli , in mucosa biopsies of individuals with Crohn's diseas”
• Mucin glycan foraging in the human gut microbiome (2015, background): “In contrast, high prevalence of aggregative, adherent Escherichia coli strains has been reported in the mucosa-associated microbiota of CD patients (Darfeuille-Michaud et al., 2004; Thomazini et al., 2011).”
• Signalling pathways and molecular interactions of NOD1 and NOD2 (2006, background): “coli ', an organism with poorly defined pathogenicity, were found in patients with Crohn's diseas”
• A microbial signature for Crohn's disease (2017, methodology): “Indeed, this tool could be combined with either imaging techniques or calprotectin data to con fi rm diagnosis.”
• Composition, variability, and temporal stability of the intestinal microbiota of the elderly (2010, background): “These clusters include organisms that are dominant or subdominant organisms in the human intestinal microbiota (9), and variations in some of them have been reported in stool of IBD patients (38); F. prausnitzii, a prominent member of Clostridium cluster IV, is also depleted in IBD (39).”
• Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body (2021, background): “coli; these strains can cross the mucosal layer causing high amounts of TNF-a production (156, 157).”
• Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis (2006, background): “coli from 22% of mucosal biopsies from Crohn's disease patients with chronic, postoperative, recurrent inflammation in the neoterminal ileum, 36% of those with early recurrence and only 6% of controls”
• NLRP6 inflammasome is a regulator of colonic microbial ecology and risk for colitis (2011, neutral): “coli (Darfeuille-Michaud et al., 2004), by reduction of tolerogenic strains such as Faecalibacterium prausnitzi (Sokol et al.”
• Dysbiosis of the gut microbiota in disease (2015, background): “coli and Mycobacterium paratuberculosis have been implicated in CD pathogenesis although a causal relationship is yet to be demonstrated (35, 36).”